SCREENING FOR RETINOPATHY NEPHROPATHY Prof V Mohan M

  • Slides: 37
Download presentation
SCREENING FOR RETINOPATHY & NEPHROPATHY Prof. V. Mohan. , M. D. , Ph. D.

SCREENING FOR RETINOPATHY & NEPHROPATHY Prof. V. Mohan. , M. D. , Ph. D. , D. Sc. DIRECTOR M. V. DIABETES SPECIALITIES CENTRE, VISITING PROFESSOR OF DIABETOLOGY SRI RAMCHANDRA MEDICAL COLLEGE, PORUR PRESIDENT MADRAS DIABETES RESEARCH FOUNDATION, CHENNAI 10/30/2021 PROFESSOR OF INTERNATIONAL HEALTH 1 UNIVERSITY OF MINNESOTA, USA

CARDINAL PRINCIPLES FOR SCREENING (WHO) 1. Important health problem with a presymptomatic state 2.

CARDINAL PRINCIPLES FOR SCREENING (WHO) 1. Important health problem with a presymptomatic state 2. Acceptable screening procedures (both by public and health care professional) 3. Safe, effective and universally agreed treatment 4. Economic cost of screening and treatment should be less than that for diagnosis and treatment

THE SCREENING PATHWAY Healthy Disease or precursor detectable Symptoms develop Advanced disease Death Screening

THE SCREENING PATHWAY Healthy Disease or precursor detectable Symptoms develop Advanced disease Death Screening possible Intervention to avert disease development or its consequence Life prolonged

CLASSIFICATION DIABETIC RETINOPATHY NON - PROLIFERATIVE DIABETIC RETINOPATHY WITHOUT MACULOPATHY WITH MACULOPATHY PROLIFERATIVE DIABETIC

CLASSIFICATION DIABETIC RETINOPATHY NON - PROLIFERATIVE DIABETIC RETINOPATHY WITHOUT MACULOPATHY WITH MACULOPATHY PROLIFERATIVE DIABETIC RETINOPATHY

VISUAL IMPAIRMENT AND RETINOPATHY By the year 2020 the number of blind people world-wide,

VISUAL IMPAIRMENT AND RETINOPATHY By the year 2020 the number of blind people world-wide, over 60 years of age will reach 54 million (Practical Optometry , 1996) 90% of the blindness in the world occurs in developing countries Diabetic retinopathy is seventh cause of blindness in India Timely treatment can prevent up to 98% of vision loss from diabetic retinopathy Less than half of those with diabetes have their eyes examined for retinopathy at the recommended frequency BJO, 2001

IS SCREENING FOR RETINOPATHY JUSTIFIED? Yes, because retinopathy…. is an important health problem has

IS SCREENING FOR RETINOPATHY JUSTIFIED? Yes, because retinopathy…. is an important health problem has a known natural history has effective treatment screening is simple to perform acceptable to patients cost effective comprehensive

DIABETIC RETINOPATHY - SCREENING M A simple diagnostic procedure, to identify those patients in

DIABETIC RETINOPATHY - SCREENING M A simple diagnostic procedure, to identify those patients in whom prompt treatment is needed to prevent loss of vision M It is not a complete clinical examination in itself

EYE EXAMINATION - ROUTINE M History M Visual acuity M Clinical examination of retina

EYE EXAMINATION - ROUTINE M History M Visual acuity M Clinical examination of retina M Direct ophthalmoscopy M Indirect ophthalmoscopy M Retinal color photography M Fluorescein angiography

OCULAR FUNCTION EXAMINATION D Visual acuity (corrected), distance, reading M Colour vision M Visual

OCULAR FUNCTION EXAMINATION D Visual acuity (corrected), distance, reading M Colour vision M Visual field test - to test confrontation eye movements D After dilation M Lens M Vitreous M Fundus including disc and macula

RETINAL EXAMINATION Ophthalmoscopy Retinal photography Polaroid photographs 35 mm colour slides Digital images -

RETINAL EXAMINATION Ophthalmoscopy Retinal photography Polaroid photographs 35 mm colour slides Digital images - Scanner - Video - Digital camera

OPHTHALMOSCOPY Direct ophthalmoscopy and indirect ophthalmoscopy through dilated pupil inexpensive, rapid, efficient

OPHTHALMOSCOPY Direct ophthalmoscopy and indirect ophthalmoscopy through dilated pupil inexpensive, rapid, efficient

OPHTHALMOSCOPY D Direct ophthalmoscopy enables adequate examination of only the posterior pole D Indirect

OPHTHALMOSCOPY D Direct ophthalmoscopy enables adequate examination of only the posterior pole D Indirect ophthalmoscopy provides insufficient magnification D Slit lamp examination using either indirect ophthalmoscopy with convex aspheric lens or diagnostic contact lens yields more information on retinal thickening and proliferative retinopathy

RETINAL PHOTOGRAPHY v Seven 30 degree fields v Two 45 degree fields v Three

RETINAL PHOTOGRAPHY v Seven 30 degree fields v Two 45 degree fields v Three photographs spread across the posterior pole

OPHTHALMOSCOPY vs PHOTOGRAPHY OPHTHALMOSCOPY No documentation PHOTOGRAPHY Can be documented is possible Errors cannot

OPHTHALMOSCOPY vs PHOTOGRAPHY OPHTHALMOSCOPY No documentation PHOTOGRAPHY Can be documented is possible Errors cannot be Photographs can be detected regraded Observer bias Mutiple grading is possible

RETINAL PHOTOGRAPHS

RETINAL PHOTOGRAPHS

RETINAL PHOTOGRAPHY

RETINAL PHOTOGRAPHY

GOLD STANDARD FOR RETINAL SCREENING Retinal photography is the gold standard for screening diabetic

GOLD STANDARD FOR RETINAL SCREENING Retinal photography is the gold standard for screening diabetic retinopathy Seven 30 - degree field of stereoscopic photographs taken by a trained technician Photographs can be taken by a mobile unit with a camera and later assessed by a trained reader Suited to serve even rural communities

SPECIFICITY AND SENSITIVITY OF OPHTHALMOSCOPY AND PHOTOGRAPHY Ophthalmoscopy (%) Sensitivity Specificity 65. 7 93.

SPECIFICITY AND SENSITIVITY OF OPHTHALMOSCOPY AND PHOTOGRAPHY Ophthalmoscopy (%) Sensitivity Specificity 65. 7 93. 8 Photography (%) 87. 3 84. 8 Owens et al, Diabetic Medicine, 1998

WHO CAN DO SCREENING ? M General practitioner M Optometrists M Clinicians in a

WHO CAN DO SCREENING ? M General practitioner M Optometrists M Clinicians in a hospital - based diabetes centre M Ophthalmologists M Diabetologists M Retinal photography services M Combination of all these

ERROR RATES FOR DIAGNOSING DIABETIC EYE DISEASE - OPHTHALMOSCOPY Overall errors (%) Serious errors

ERROR RATES FOR DIAGNOSING DIABETIC EYE DISEASE - OPHTHALMOSCOPY Overall errors (%) Serious errors (%) Internist 74 70 Senior medical resident 69 52 Diabetologist 66 50 Ophthalmologist 48 11 Retinal specialist 13 0

NATURAL HISTORY OF NEPHROPATHY IN TYPE 1 DIABETES Normo albuminuria Stage of hyperfiltration Micro

NATURAL HISTORY OF NEPHROPATHY IN TYPE 1 DIABETES Normo albuminuria Stage of hyperfiltration Micro albuminuria 15 - 20 yrs Macro albuminuria Azotemia End stage (Renal failure) disease 4 - 5 yrs 1 yrs

PREVALENCE OF DIABETIC NEPHROPATHY Diabetic Nephropathy | Develops in 35 - 45% of Type

PREVALENCE OF DIABETIC NEPHROPATHY Diabetic Nephropathy | Develops in 35 - 45% of Type 1 diabetic patients | 20 - 30% of Type 2 diabetic patients | Leading cause of ESRD in United States

PREVALENCE OF DIABETIC NEPHROPATHY IN DIFFERENT ETHNIC GROUPS 19 million Indians with diabetes 5

PREVALENCE OF DIABETIC NEPHROPATHY IN DIFFERENT ETHNIC GROUPS 19 million Indians with diabetes 5 - 60% of type 2 diabetes depending on ethnic origin Caucasians - 5 - 10% African Americans - 10 - 20% Pima Indians - 60% Asian Indians - 10% Even with 10%, 1. 7 million Indian diabetics will have Nephropathy

SCREENING FOR MICROALBUMINURIA Routine urinalysis for protein Overt nephropathy - For protein + For

SCREENING FOR MICROALBUMINURIA Routine urinalysis for protein Overt nephropathy - For protein + For protein Quantitative protein begin treatment Repeat in 1 year Condition that may Yes invalidate urine Wait until resolved albumin excretion No No Test for microalbumin > 30 mg/24 h Yes Repeat microalbumin test twice within 3 months period 2 of 3 tests > 30 mg/24 h ? Yes Microalbuminuria, begin treatment

SPECIMEN COLLECTION Collect freshly voided urine in a clean, dry container Preservatives should be

SPECIMEN COLLECTION Collect freshly voided urine in a clean, dry container Preservatives should be avoided Samples which cannot be tested within 3 days of collection should be refrigerated Samples should not be frozen The test should be free from significant interference from glucosuria, p. H, ketonuria or bacterial contamination

SCREENING FOR MICROALBUMINURIA Three methods Albumin to creatinine ratio in random spot collection 24

SCREENING FOR MICROALBUMINURIA Three methods Albumin to creatinine ratio in random spot collection 24 - h urine collection with creatinine Timed collection (4 -h or overnight)

DEFINITION OF MICROALBUMINURIA Stage Normoalbuminuria Microalbuminuria Clinical albuminuria 24 h collection < 30 mg/24

DEFINITION OF MICROALBUMINURIA Stage Normoalbuminuria Microalbuminuria Clinical albuminuria 24 h collection < 30 mg/24 h Timed collection <20 g/min Spot collection <30 g/mg creat 30 -300 mg/24 h 20 -200 g/min 30 -300 g/mg creat >300 mg/24 h >200 g/min >300 g/mg creat ADA, Diabetes Care, 1998

ADVANTAGES AND DISADVANTAGES METHODS OF MICROALBUMINURIA ANALYSIS Random spot collection First void or morning

ADVANTAGES AND DISADVANTAGES METHODS OF MICROALBUMINURIA ANALYSIS Random spot collection First void or morning collection Timed collection Easy to perform Generally provides accurate information Preferred due to diurnal variation in albumin excretion Gold standard Notoriously labour and time intensive Patients co-operation difficult

SPECIFICITY AND SENSITIVITY FOR MICROALBUMINURIA Timed urine collection - gold standard Sensitivity (%) Specificity

SPECIFICITY AND SENSITIVITY FOR MICROALBUMINURIA Timed urine collection - gold standard Sensitivity (%) Specificity (%) Random spot specimen 89 85 First morning void 70 93 Schwab et al, Diabetes Care, 1992

SHORTENED TIMED CLEARANCES SUGGESTIONS …. . 3 -hour collections 4 -hour collections Brodows et

SHORTENED TIMED CLEARANCES SUGGESTIONS …. . 3 -hour collections 4 -hour collections Brodows et al, Diabetes Care, 1981 Steno study group, Lancet, 1982 1 -hour timed collections Sochett et al, J. Pediatr, 1988 Overnight collections Viberti et al , Lancet, 1982

ASSAYS FOR MICROALBUMINURIA Qualitative Dipstick method Quantitative Radioimmuno assay Immunoturbidometric assay Enzyme linked Immunosorbant

ASSAYS FOR MICROALBUMINURIA Qualitative Dipstick method Quantitative Radioimmuno assay Immunoturbidometric assay Enzyme linked Immunosorbant assay

MICRAL STRIPS Micral strip screening tests offer a costeffective method of screening Dip sticks

MICRAL STRIPS Micral strip screening tests offer a costeffective method of screening Dip sticks show acceptable sensitivity (95%) and specificity (93%) All positive tests should be confirmed by more specific methods

FALSE POSITIVES FOR ALBUMINURIA Hyperfiltration (Newly diagnosed diabetes) Exercise Marked hypertension Congestive Heart Failure

FALSE POSITIVES FOR ALBUMINURIA Hyperfiltration (Newly diagnosed diabetes) Exercise Marked hypertension Congestive Heart Failure Urinary Tract Infection Acute febrile illness

CONCLUSIONS Screening for retinopathy Sensitive, specific and safe screening tests are available for retinopathy

CONCLUSIONS Screening for retinopathy Sensitive, specific and safe screening tests are available for retinopathy Retinal photography is the gold standard, which can be modified from seven to four field Training is necessary to grade retinal photographs Newer technologies including digital imaging may reduce the cost of screening

PRIORITIES For preventing blindness due to diabetes ` Screening ` Diagnosis ` Treatment `

PRIORITIES For preventing blindness due to diabetes ` Screening ` Diagnosis ` Treatment ` Counseling ` Education For all diabetic patients

CONCLUSIONS Screening for nephropathy Screening tests for microalbuminuria are safe, simple at the same

CONCLUSIONS Screening for nephropathy Screening tests for microalbuminuria are safe, simple at the same time specific and sensitive Timed urine collection is the gold standard. However spot urine testing has also proved to be equally sensitive Micral dip sticks are cost effective Microalbuminuria provides information not only about nephropathy, but also generalized vascular disease (endothelial dysfunction)

PRIORITIES For preventing nephropathy due to diabetes ` Annual screening of Microalbuminuria ` Glycemic

PRIORITIES For preventing nephropathy due to diabetes ` Annual screening of Microalbuminuria ` Glycemic control ` Treatment modalities to slow down the rate of progression of nephropathy in all diabetic patients